Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global real-time PCR, digital PCR, and end-point PCR market size was exhibited at USD 34.32 billion in 2022 and is projected to hit around USD 76.18 billion by 2032, growing at a CAGR of 8.3% during the forecast period 2023 to 2032.

Key Pointers:

• The clinical segment held the largest revenue share of over 86.7% in 2022.
• The consumables and reagents segment held the largest revenue share of over 61.17% in 2022.
• The quantitative PCR segment held the largest revenue share of over 86.7% in 2022. 
• North America dominated the global market with a revenue share of over 36.9% in 2022

 Real-time PCR, Digital PCR, And End-point PCR Market Report Scope

The real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2032. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.

The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.

Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.

Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.

Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period. 

Some of the prominent players in the Real-time PCR, digital PCR, and end-point PCR Market include:

• Abbott
• Qiagen
• Bio-Rad Laboratories Inc.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• GE Healthcare
• BIOMÉRIEUX
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Real-time PCR, digital PCR, and end-point PCR market.

By Technology 

• Quantitative
  • Consumables & Reagents
  • Instruments
  • Software & Services
• Digital
  • Consumables & Reagents
  • Instruments
  • Software & Services
• End-point
  • Consumables & Reagents
  • Instruments
  • Software & Services

By Product 

• Consumables & Reagents
• Instruments
• Software & Services

By Application 

• Clinical
  • Pathogen Testing
  • Oncology testing
  • Blood Screening
  • Liquid Biopsy
  • dPCR-based Non-invasive Prenatal Testing (NIPT)
  • Others
• Research
• Stem Cell Research
  • DNA Cloning & Sequencing
  • Recombinant DNA Technology
  • Rare Mutation Detection
  • Gene Expression
  • Single Cell Analysis
  • Microbiome Analysis
  • Copy Number Variation Analysis
  • Library Quantification (NGS)
  • Characterization of Low-fold Changes in mRNA and miRNA
  • Expression"
  • Species Identification
  • GMO Detection
  • Others
• Forensic

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)